Nicholas Hoffman & Company, LLC.

SEC CIK: 0001678953
Latest filing: Aug 4, 2026

SEC filings (opens in a new tab)

GSK holding history

GSK plc in every 13F filed by Nicholas Hoffman & Company, LLC., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

GSK overview All 13F holders of GSK Full Q2 2026 holdings

Shares (Q2 2026): 37,580
Value: $1.97M
% of portfolio: <0.1%
Quarters held: 22; Since Q1 2021

Holdings of GSK by Nicholas Hoffman & Company, LLC., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	37,580	$1.97M	<0.1%	−330−0.9%	Reduced	Holders
Q1 2026	37,910	$2.09M	<0.1%	−7,040−15.7%	Reduced	Holders
Q4 2025	44,950	$2.20M	0.1%	−2,648−5.6%	Reduced	Holders
Q3 2025	47,598	$2.05M	<0.1%	−35−0.1%	Reduced	Holders
Q2 2025	47,633	$1.83M	<0.1%	−193−0.4%	Reduced	Holders
Q1 2025	47,826	$1.85M	0.1%	+650+1.4%	Added	Holders
Q4 2024	47,176	$1.60M	0.1%	+6,721+16.6%	Added	Holders
Q3 2024	40,455	$1.65M	0.1%	−1,032−2.5%	Reduced	Holders
Q2 2024	41,487	$1.60M	0.1%	−70.0%	Reduced	Holders
Q1 2024	41,494	$1.78M	0.1%	−563−1.3%	Reduced	Holders
Q4 2023	42,057	$1.56M	0.1%	−1,139−2.6%	Reduced	Holders
Q3 2023	43,196	$1.57M	0.1%	−426−1.0%	Reduced	Holders
Q2 2023	43,622	$1.55M	0.1%	−478−1.1%	Reduced	Holders
Q1 2023	44,100	$1.57M	0.1%	+1,187+2.8%	Added	Holders
Q4 2022	42,913	$1.51M	0.2%	−1,178−2.7%	Reduced	Holders
Q3 2022	44,091	$1.30M	0.1%	−4,650−9.5%	Reduced	Holders
Q2 2022	48,741	$2.12M	0.1%	+603+1.3%	Added	Holders
Q1 2022	48,138	$2.10M	0.1%	−55−0.1%	Reduced	Holders
Q4 2021	48,193	$2.13M	0.1%	−1,081−2.2%	Reduced	Holders
Q3 2021	49,274	$1.88M	0.3%	−453−0.9%	Reduced	Holders
Q2 2021	49,727	$1.98M	0.4%	+574+1.2%	Added	Holders
Q1 2021	49,153	$1.75M	0.4%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.